Quality of Life and Patient-reported Outcomes in the Older Breast Cancer Patient

Clinical Oncology

Volumn 21, Issue 2, 2009, Pages 140-155

  Ballinger, R S ^a   Fallowfield, L J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Breast cancer; older patient; patient reported outcomes; quality of life; review

Indexed keywords

ANTINEOPLASTIC AGENT; LETROZOLE; TAMOXIFEN;

AGE DISTRIBUTION; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REHABILITATION; CANCER SURVIVAL; CLINICAL TRIAL; DRUG RESPONSE; ELDERLY CARE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECURRENT CANCER; SHORT FORM 36; WELLBEING;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; QUALITY OF LIFE; SURVIVORS;

EID: 59249086043     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.11.003     Document Type: Article

References (121)

1. United Nations Department of Economic and Social Affairs. Population Department. World population ageing 2007. http://www.un.org/esa/population/publications/WPA2007/ES-English.pdf [accessed 30.04.08]
2. Cancer Research UK. Incidence and mortality in the European Union. http://info.cancerresearchuk.org/cancerstats/geographic/cancerineu/incid enceandmortality/ [accessed 30.04.08]
3. SEER. Surveillance epidemiology and end results fast stats. http://seer.cancer.gov/faststats/selections.php#Output [accessed 30.04.08]
4. Cancer Research UK. Breast cancer key statistics. http://info.cancerresearchuk.org/cancerstats/types/breast/ [accessed 03.04.08]
5. Wildiers H., Kunkler I., Biganzoli L., et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8 (2007) 1101-1115
6. Crivellari D., Aapro M., Leonard R., et al. Breast cancer in the elderly. J Clin Oncol 25 (2007) 1882-1890
7. Garcia S.F., Cella D., Clauser S.B., et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 25 (2007) 5106-5112
8. Lipscomb J., Gotay C.C., and Snyder C.F. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 57 (2007) 278-300
9. Efficace F., Novik A., Vignetti M., Mandelli F., and Cleeland C.S. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?. Haematologica 92 (2007) 1596-1598
10. Lavelle K., Todd C., Moran A., Howell A., Bundred N., and Campbell M. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or = 65 years. Br J Cancer 96 (2007) 1197-1203
11. Bouchardy C., Rapiti E., Blagojevic S., Vlastos A.-T., and Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 25 (2007) 1858-1869
12. Efficace F., Bottomley A., Osoba D., et al. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials - does HRQOL evaluation in prostate cancer research inform clinical decision making?. J Clin Oncol 21 (2003) 3502-3511
13. Blazeby J.M., Avery K., Sprangers M., Pikhart H., Fayers P., and Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 24 (2006) 3178-3186
14. Mandelblatt J., Figueiredo M., and Cullen J. Outcomes and quality of life following breast cancer treatment in older women: when, why, how much, and what do women want?. Health Qual Life Outcomes 1 (2003) 45
15. Detmar S.B., Aaronson N.K., Wever L.D.V., Muller M., and Schornagel J.H. How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol 18 (2000) 3295-3301
16. Liang W., Burnett C.B., Rowland J.H., et al. Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol 20 4 (2002) 1008-1016
17. Polsky D., Keating N., Weeks J., and Schulman K. Patient choice of breast cancer treatment: impact on health state preferences. Med Care 40 (2002) 1068-1079
18. Bottomley A., Flechtner H., Efficace F., et al. Health related quality of life outcomes in cancer clinical trials. Eur J Cancer 41 (2005) 1697-1709
19. de Haes J.C.J.M., Curran D., Aaronson N.K., and Fentiman I.S. Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer 39 7 (2003) 945-951
20. Pasetto L.M., Falci C., Compostella A., Sinigaglia G., and Rossi E. Quality of life in elderly cancer patients. Eur J Cancer 43 (2007) 1508-1513
21. Rao A., and Demark-Wahnefried W. The older cancer survivor. Crit Rev Oncol Hematol 60 2 (2006) 131-143
22. Wedding U., Pientka L., and Hoffken K. Quality-of-life in elderly patients with cancer: a short review. Eur J Cancer 43 15 (2007) 2203-2210
23. Mols F., Vingerhoets A.J.J.M., Coebergh J.W., and van de Poll-Franse L.V. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41 (2005) 2613-2619
24. Ershler W.B. Capecitabine use in geriatric oncology: an analysis of current safety, efficacy, and quality of life data. Crit Rev Oncol Hematol 58 (2006) 68-78
25. Tallarico M., Figueiredo M., Goodman M., Kreling B., and Mandelblatt J. Psychosocial determinants and outcomes of chemotherapy in older women with breast cancer: What do we know? What do we need to know?. Cancer J 11 (2005) 518-528
26. Balducci L., and Extermann M. Management of cancer in the older person: a practical approach. Oncologist 5 (2000) 224-237
27. Fitzsimmons D. What are we trying to measure? Rethinking approaches to health outcome assessment for the older person with cancer. Eur J Cancer Care (Engl) 13 (2004) 416-423
28. Hurria A., Gupta S., Zauderer M., et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 104 (2005) 1998-2005
29. Di Maio M., and Perrone F. Quality of life in elderly patients with cancer. Health Qual Life Outcomes 1 (2003) 44
30. Hahn E., and Cella D. Health outcomes assessment in vulnerable populations: measurement challenges and recommendations. Arch Phys Med Rehabil 84 4 Suppl 2 (2003) S35-S42
31. Fallowfield L. Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer. Breast Cancer Res 9 Suppl 2 (2007) S7
32. ® Health Survey update. http://www.sf-36.org/tools/sf36.shtml [accessed 22.04.08]
33. ® Health Survey manual and interpretation guide (1993), New England Medical Center, The Health Institute, Boston, MA
34. Ferrer M. The use of the Short Form (SF)-36 questionnaire for older adults. Age Ageing 27 (1998) 755
35. Hayes V., Morris J., and Wolfe C. The SF-36 health survey questionnaire: is it suitable for use with older adults?. Age Ageing 24 (1995) 120-125
36. Spielberger C.D. Manual for the State-Trait Anxiety Inventory (1983), Consulting Psychologists Press, Palo Alto, CA
37. Dennis R., and Boddington S.J. Self-report measures of anxiety: are they suitable for older adults?. Aging Ment Health 11 (2007) 668-677
38. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
39. Ford M., and Havstad S.L. Assessing the reliability of the EORTC QLQ-C30 in a sample of older African American and Caucasian adults. Qual Life Res 10 (2001) 533-541
40. Sprangers M., Cull A., Bjordal K., and Groenvold M. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 2 (1993) 287-295
41. Sprangers M.A., Groenvold M., Arraras J.I., et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14 (1996) 2756-2768
42. Cella D., Tulsky D.S., Gray G., et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
43. FACIT. Functional assessment of chronic illness therapy. http://www.facit.org/qview/qlist.aspx [accessed 29.04.08]
44. Overcash J., Extermann M., Parr J., and Perry J. Validity and reliability of the FACT-G scale for use in the older person with cancer. Am J Clin Oncol 24 (2001) 591-596
45. Brady M.J., Cella D.F., Mo F., et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15 (1997) 974-986
46. Hickey A., Barker M., McGee H., and O'Boyle C. Measuring health-related quality of life in older patient populations: a review of current approaches. Pharmacoeconomics 23 (2005) 971-993
47. Aapro M., and Johnson C.D. The elderly: geriatric oncology finally deserving adequate attention. Eur J Cancer 43 (2007) 2312-2314
48. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/results?term = breast+cancer+elderly [accessed 30.04.08]
49. UK Clinical Research Network Study Portfolio. http://public.ukcrn.org.uk/Search/Portfolio.aspx?level1=1&level2=3 [accessed 30.04.08]
50. National Cancer Institute. Clinical trials search results. http://www.cancer.gov/search/ResultsClinicalTrials.aspx?protocolsearchid =4496758# [accessed 30.04.08]
51. International Breast Cancer Study Group. Open clinical trials. http://www.ibcsg.org/public/general_pages/trials/open/pub_trials_open.sh tml [accessed 30.04.08]
52. Cella D., Fallowfield L., Barker P., et al. Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Res Treat 100 (2006) 273-284
53. Fallowfield L.J., Bliss J.M., Porter L.S., et al. Quality of life in the Intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 24 (2006) 910-917
54. International Breast Cancer Study Group. Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93. Ann Oncol 15 (2004) 1749-1759
55. Lavelle K., Moran A., Howell A., Bundred N., Campbell M., and Todd C. Older women with operable breast cancer are less likely to have surgery. Br J Surg 94 (2007) 1209-1215
56. International Breast Cancer Study Group. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 24 (2006) 337-344
57. Fleissig A., Fallowfield L., Langridge C., et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95 (2006) 279-293
58. Engel J., Kerr J., Schlesinger-Raab A., Sauer H., and Holzel D. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J 10 (2004) 223-231
59. Kenefick A. Patterns of symptom distress in older women after surgical treatment for breast cancer. Oncol Nurs Forum 33 (2006) 327-335
60. Aapro M. State of the art therapy for elderly patients with early-stage and locally advanced breast cancer. Eur J Cancer 6 Suppl (2008) 22-27
61. Pusic A., Chen C., Cano S., et al. Measuring quality of life in cosmetic and reconstructive breast surgery: a systematic review of patient-reported outcomes instruments. Plast Reconstr Surg 120 (2007) 823-837 discussion 838-839]
62. EORTC quality of life module for breast reconstruction. http://groups.eortc.be/qol/qolg_projects.htm#breast_reconstruction [accessed 08.05.08]
63. Girotto J., Schreiber J., and Nahabedian M. Breast reconstruction in the elderly: preserving excellent quality of life. Ann Plast Surg 50 (2003) 572-578
64. Hopwood P., Haviland J., Mills J., Sumo G., and Bliss J. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast 16 (2007) 241-251
65. Rayan G., Dawson L.A., Bezjak A., et al. Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 154-161
66. Mbarek B., Galalae R., Michel J., Siebmann J., and Kuchler T. Impact of age on health-related quality of life (HR-QOL) in women with breast cancer treated by conserving surgery and postoperative 3D-radiotherapy. Radiother Oncol 73 (2004) S250
67. Prescott R., Kunkler I., Williams L., et al. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess 11 31 (2007) 1-149 iii-iv
68. Arraras J.I., Arias F., Manterola A., et al. Impact of radiotherapy on quality of life in elder women with localized breast cancer. A prospective study. ASCO Meeting Abstracts 25 18 Suppl (2007) 19656
69. Whelan T.J., Goss P.E., Ingle J.N., et al. Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol 23 (2005) 6931-6940
70. Muss H.B., Tu D., Ingle J.N., et al. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG Intergroup Trial MA.17. J Clin Oncol 26 (2008) 1956-1964
71. Hind D., Wyld L., Beverley C., and Reed M. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database Syst Rev 1 (2006) CD004272
72. Fallowfield L. Quality of life in the elderly woman with breast cancer treated with tamoxifen and surgery or tamoxifen alone. J Women's Health 3 1 (1994) 17-20
73. Muss H. Adjuvant treatment of elderly breast cancer patients. Breast 16 Suppl 2 (2007) S159-S165
74. Browall M., Ahlberg K.M., Persson L.O., and Karlsson P.O. The impact of age on health-related quality of life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy. Acta Oncol 47 (2008) 207-215
75. Watters J.M., Yau J.C., O'Rourke K., Tomiak E., and Gertler S.Z. Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer. Ann Oncol 14 (2003) 1744-1750
76. Browall M., Ahlberg K., Karlsson P., Danielson E., and Persson L.O. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women. Eur J Oncol Nurs 12 3 (2008) 180-189
77. Jones S.E., Erban J., Overmoyer B., et al. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 23 (2005) 5542-5551
78. Martin M., Lluch A., Segui M.A., et al. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Ann Oncol 17 (2006) 1205-1212
79. Chang J., Couture F., Young S., McWatters K.-L., and Lau C.Y. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J Clin Oncol 23 (2005) 2597-2605
80. Bottomley A., Biganzoli L., Cufer T., et al. Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study. J Clin Oncol 22 (2004) 2576-2586
81. Monfardini S., Gridelli C., Pasetto L., Soubeyran P., Droz J., and Basso U. Vulnerable and frail elderly: an approach to the management of the main tumour types. Eur J Cancer 44 (2008) 488-493
82. Crivellari D., Bonetti M., Castiglione-Gertsch M., et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol 18 (2000) 1412-1422
83. Kurtz J., and Dufour P. Strategies for improving quality of life in older patients with metastatic breast cancer. Drugs Aging 19 (2002) 605-622
84. Hurria A., Zuckerman E., Panageas K., et al. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc 54 (2006) 1119-1124
85. Baker F., Haffer S., and Denniston M. Health-related quality of life of cancer and noncancer patients in Medicare managed care. Cancer 97 (2003) 674-681
86. Arndt V., Merx H., Sturmer T., Stegmaier C., Ziegler H., and Brenner H. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer 40 (2004) 673-680
87. Ganz P.A., Guadagnoli E., Landrum M.B., Lash T.L., Rakowski W., and Silliman R.A. Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21 (2003) 4027-4033
88. Sweeney C., Schmitz K.H., Lazovich D., Virnig B.A., Wallace R.B., and Folsom A.R. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst 98 (2006) 521-529
89. Mandelblatt J.S., Edge S.B., Meropol N.J., et al. Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. J Clin Oncol 21 (2003) 855-863
90. Mehnert A., and Koch U. Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res 64 (2008) 383-391
91. Robb C., Haley W., Balducci L., et al. Impact of breast cancer survivorship on quality of life in older women. Crit Rev Oncol Hematol 62 (2007) 84-91
92. Fehlauer F., Tribius S., Mehnert A., and Rades D. Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy. Breast Cancer Res Treat 92 (2005) 217-222
93. Stommel M., Kurtz M., Kurtz J., Given C., and Given B. A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol 23 (2004) 564-573
94. Deimling G., Sterns S., Bowman K., and Kahana B. The health of older-adult, long-term cancer survivors. Cancer Nurs 28 (2005) 415-424
95. Deimling G., Bowman K., Sterns S., Wagner L., and Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology 15 (2006) 306-320
96. Sammarco A. Quality of life among older survivors of breast cancer. Cancer Nurs 26 (2003) 431-438
97. Stava C., Lopez A., and Vassilopoulou-Sellin R. Health profiles of younger and older breast cancer survivors. Cancer 107 (2006) 1752-1759
98. Heidrich S., Egan J., Hengudomsub P., and Randolph S. Symptoms, symptom beliefs, and quality of life of older breast cancer survivors: a comparative study. Oncol Nurs Forum 33 (2006) 315-322
99. Griggs J., Sorbero M., Mallinger J., et al. Vitality, mental health, and satisfaction with information after breast cancer. Patient Educ Couns 66 (2007) 58-66
100. Strauss-Blasche G., Gnad E., Ekmekcioglu C., Hladschik B., and Marktl W. Combined inpatient rehabilitation and spa therapy for breast cancer patients: effects on quality of life and CA 15-3. Cancer Nurs 28 (2005) 390-398
101. Kornblith A., Dowell J., Herndon J., et al. Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a Cancer and Leukemia Group B study. Cancer 107 (2006) 2706-2714
102. Kenne Sarenmalm E., Ohlen J., Jonsson T., and Gaston-Johansson F. Coping with recurrent breast cancer: predictors of distressing symptoms and health-related quality of life. J Pain Symptom Manage 34 (2007) 24-39
103. Extermann M., Meyer J., McGinnis M., et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 49 (2004) 69-75
104. Jennings-Sanders A., and Anderson E. Older women with breast cancer: perceptions of the effectiveness of nurse case managers. Nurs Outlook 51 (2003) 108-114
105. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/home [accessed 20.04.08]
106. ClinicalTrials.gov. Adjuvant capecitabine in elderly patients with breast cancer: a phase II study. http://clinicaltrials.gov/ct2/show/NCT00263705?term=breast+cancer+elderl y&rank=2 [accessed 30.04.08]
107. ClinicalTrials.gov. Study in elderly patients with early breast cancer (ICE). http://clinicaltrials.gov/ct2/show/NCT00196859?term=breast+cancer+elderl y&rank=3 [accessed 30.04.08]
108. ClinicalTrials.gov. ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment. http://clinicaltrials.gov/ct2/show/NCT00331097?term=breast+cancer+elderl y&rank=5 [accessed 30.04.08]
109. ClinicalTrials.gov. Pegylated liposomal doxorubicin (Caelyx(R)) as monotherapy in elderly patients with locally advanced and/or metastatic breast cancer (study P05059 AM2). http://clinicaltrials.gov/ct2/show/NCT00604968?term=breast+cancer+elderl y&rank=6 [accessed 30.04.08]
110. ClinicalTrials.gov. Gemcitabine in treating elderly women with metastatic breast cancer. http://clinicaltrials.gov/ct2/show/NCT00005614?term=breast+cancer+elderl y&rank=10 [accessed 30.04.08]
111. ClinicalTrials.gov. Combination chemotherapy compared with mitoxantrone in treating older patients with advanced breast cancer. http://clinicaltrials.gov/ct2/show/NCT00002498?term=breast+cancer+elderl y&rank=14 [accessed 30.04.08]
112. ClinicalTrials.gov. Capecitabine and vinorelbine in treating older women who have metastatic breast cancer with or without bone involvement. http://clinicaltrials.gov/ct2/show/NCT00003902?term=breast+cancer+elderl y&rank=15 [accessed 30.04.08]
113. ClinicalTrials.gov. Docetaxel in treating older women with metastatic breast cancer. http://clinicaltrials.gov/ct2/show/NCT00025493?term=breast+cancer+elderl y&rank=21 [accessed 30.04.08]
114. ® as first line chemotherapy for metastatic breast cancer in women 60 years and older. http://clinicaltrials.gov/ct2/show/NCT00082095?term=breast+cancer+elderl y&rank=19 [accessed 30.04.08]
115. ClinicalTrials.gov. Reduced dexamethasone pre-medication dose in elderly patients receiving weekly docetaxel. http://clinicaltrials.gov/ct2/show/NCT00215748?term=breast+cancer+elderl y&rank=8 [accessed 30.04.08]
116. Crivellari D. BIG 1-05/IBCSG 32-05 CASA premature closure of elderly trial. Breast International Group newsletter (2008) 23
117. ClinicalTrials.gov. Surgery with or without lymph node removal in treating older women with stage I or stage IIA breast cancer. http://clinicaltrials.gov/ct2/show/NCT00002528?term=breast+cancer+elderl y&rank=13 [accessed 30.04.08]
118. ClinicalTrials.gov. Partial breast radiation to the lumpectomy cavity with IMRT in elderly women. http://clinicaltrials.gov/ct2/show/NCT00337064?term=breast+cancer+elderl y&rank=7 [accessed 30.04.08]
119. ClinicalTrials.gov. Radiation therapy in treating older women who are undergoing surgery for stage I or stage II breast cancer. http://clinicaltrials.gov/ct2/show/NCT00104702?term=breast+cancer+elderl y&rank=22 [accessed 30.04.08]
120. ClinicalTrials.gov. Evaluation of accelerated partial breast brachytherapy. http://clinicaltrials.gov/ct2/show/NCT00593346?term=breast+cancer+elderl y&rank=27 [accessed 30.04.08]
121. ClinicalTrials.gov. Strength training for older breast cancer survivors. http://clinicaltrials.gov/ct2/show/NCT00591747?term=breast+cancer+elderl y&rank=11 [accessed 30.04.08]